Kiniksa Pharmaceuticals International, plc Cash and Restricted Cash
Kiniksa Pharmaceuticals International, plc (KNSA) had Cash and Restricted Cash of $189.95 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-28
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $189.95M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $165.60M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $174.86M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $192.04M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $189.95M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $165.60M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $174.86M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $192.04M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $157.13M 10-Q · filed 2026-04-28 |
| 2024-12-31 | $183.58M 10-Q · filed 2026-04-28 |
| 2024-09-30 | $97.38M 10-Q · filed 2025-10-28 |
| 2024-06-30 | $99.27M 10-Q · filed 2025-07-29 |
| 2024-03-31 | $141.08M 10-Q · filed 2025-04-29 |
| 2023-12-31 | $107.95M 10-K · filed 2026-02-24 |
| 2023-09-30 | $117.83M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $112.57M 10-Q · filed 2024-07-25 |
| 2023-03-31 | $80.62M 10-Q · filed 2024-04-25 |
| 2022-12-31 | $122.72M 10-K · filed 2026-02-24 |
| 2022-09-30 | $175.76M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $94.31M 10-Q · filed 2023-08-01 |
| 2022-03-31 | $63.32M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $122.47M 10-K · filed 2025-02-25 |
| 2021-09-30 | $190.18M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $168.16M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $120.07M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $114.25M 10-K · filed 2024-02-28 |
| 2020-09-30 | $86.08M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $123.67M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $106.55M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $47.14M 10-K · filed 2023-03-02 |
| 2019-09-30 | $69.02M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $83.02M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $82.84M 10-Q · filed 2020-05-04 |
| 2018-12-31 | $72.19M 10-K · filed 2022-02-24 |
| 2018-09-30 | $69.87M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $285.99M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $221.42M 10-Q · filed 2019-05-07 |
| 2017-12-31 | $45.66M 10-K · filed 2021-02-25 |
| 2017-09-30 | $69.04M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $80.01M 10-Q · filed 2018-08-06 |
| 2016-12-31 | $56.08M 10-K · filed 2019-03-12 |